首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

2084766

氫可酮、Buprenornhine及其他藥物市場：按藥物、應用、給藥途徑、分銷管道和地區分類

Morphine, Buprenorphine, and Other Drugs Market, By Drug, By Application, By Route Of Administration, By Distribution Channel, By Geography

出版日期: 2026年06月25日 | 出版商:

Coherent Market Insights | 英文 258 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

氫可酮、Buprenornhine和其他藥品市場預計在2026年達到99.4億美元，預計2033年將達到139.7億美元。預計從2026年到2033年，該市場將以6.2%的複合年成長率成長。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	99.4億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	6.20%	預計金額（2033 年）	139.7億美元

氫可酮、Buprenornhine和其他類似藥物統稱為鴉片類藥物。鴉片是一種深棕色樹脂狀物質，提取自罌粟的蒴果，含有生物鹼。鴉片類藥物包括氫可酮、Buprenornhine、那可汀、蒂巴因、依托芬和其他類似物質。氫可酮是鴉片中的主要生物鹼，被認為是此類藥物的代表。鴉片類藥物具有鎮靜和鎮痛作用，常用於疼痛管理。鴉片類藥物通常用於治療創傷性疼痛、內臟疼痛、缺血性疼痛、術後疼痛、燒傷疼痛和癌症疼痛。市場成長主要歸因於全球癌症發生率的上升。

市場動態

推動全球氫可酮、Buprenornhine及其他藥物市場成長的主要因素是癌症、慢性疼痛（術後疼痛、背痛）、關節炎和纖維肌痛等疾病的日益普遍。多種鴉片類止痛藥被推薦用於治療癌症患者的中度至重度疼痛。例如，根據美國疾病管制與預防中心（CDC）的數據，癌症是美國的主要死因之一。此外，根據2021年美國癌症統計數據，2018年有1,708,923名美國人被診斷出罹患癌症。因此，癌症的高發生率以及鴉片類藥物在癌症治療中的應用預計將推動市場成長。

本報告的主要特點

本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
本節根據各種參數（公司概況、產品系列、主要趨勢、財務表現、策略等）對全球氫可酮、Buprenornhine和其他藥品市場的主要公司進行介紹。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
《全球氫可酮、Buprenornhine及其他藥品市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球氫可酮、Buprenornhine和其他藥品市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Purdue Pharma
- Sun Pharmaceuticals
- Pfizer Inc.
- West Ward Pharmaceuticals
- Teva Pharmaceuticals
- Piramal Pharmaceuticals
- Hikama Pharmaceuticals
- Indivior PLC
- Oreoxo AB
- Camurus AB
- Novartis
分析師意見

第10章

參考
分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI4637

Morphine, Buprenorphine, and Other Drugs Market is estimated to be valued at USD 9.94 Bn in 2026 and is expected to reach USD 13.97 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 9.94 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.20%	2033 Value Projection:	USD 13.97 Bn

Morphine, buprenorphine, and other similar drugs are known as opioid drugs. Opium is dark brown, resinous material obtained from poppy capsule called opium containing alkaloids. Opioids include morphine, buprenorphine, noscapine, thebaine, etrophine, and other similar substances. Morphine is principle alkaloid in opium and is described prototype of this class of drugs. Opioids have sedative and analgesic effects, and are commonly used for pain management. Opioids are commonly indicated in traumatic, visceral, ischaemic, postoperative burn, and cancer pain. The growth in the market can be primarily attributed to the growing prevalence of cancer worldwide.

Market Dynamics

The key drivers contributing to the global morphine, buprenorphine and other drug market's growth is the increase in prevalence of diseases such as cancer, chronic pain (post-surgical pain, lower back pain), arthritis, and fibromyalgia. Several narcotic drugs are recommended for the management of moderate to severe pain in cancer patients. For instance, according to Centers for Disease Control and Prevention (CDC) cancer is one of leading causes of deaths in the U.S. Furthermore, according to U.S. Cancer Statistics of 2021 in 2018 1,708,923 Americans were diagnosed with cancer. Thus, owing to prevalence of cancer and use of opioids for treatment of cancer is expected to drive the market growth.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the morphine, buprenorphine and other drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Purdue Pharma, Sun Pharmaceuticals, Pfizer Inc. , West Ward Pharmaceuticals, Teva Pharmaceuticals, Piramal Pharmaceuticals, Hikama Pharmaceuticals, Indivior PLC, Oreoxo AB, Camurus AB, and Novartis
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The morphine, buprenorphine, and other drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global morphine, buprenorphine, and other drugs market

Market Segmentation

By Drug (Revenue, USD Bn, 2021-2033)
Morphine
Buprenorphine
Noscapin
Thebaine
Etrophine
By Application (Revenue, USD Bn, 2021-2033)
Pain Management
Opioid Addiction Treatment
Others
By Route Of Administration (Revenue, USD Bn, 2021-2033)
Injectable
Oral
Transdermal
By Distribution Channel (Revenue, USD Bn, 2021-2033)
Hospital Pharmacies
Retail Pharmacies
Others
By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
Purdue Pharma
Sun Pharmaceuticals
Pfizer Inc.
West Ward Pharmaceuticals
Teva Pharmaceuticals
Piramal Pharmaceuticals
Hikama Pharmaceuticals
Indivior PLC
Oreoxo AB
Camurus AB
Novartis

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug
- Market Snapshot, By Application
- Market Snapshot, By Route Of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Morphine, Buprenorphine, and Other Drugs Market, By Drug, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Morphine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Buprenorphine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Noscapine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Thebaine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Etrophine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Morphine, Buprenorphine, and Other Drugs Market, By Application, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Opioid Addiction Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Morphine, Buprenorphine, and Other Drugs Market, By Route Of Administration, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Transdermal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Morphine, Buprenorphine, and Other Drugs Market, By Distribution Channel, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

8. Morphine, Buprenorphine, and Other Drugs Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Route Of Administration, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Purdue Pharma
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Sun Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- West Ward Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Teva Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Piramal Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Hikama Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Indivior PLC
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Oreoxo AB
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Camurus AB
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Novartis
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views

10. Section

References
Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

醫用氫可酮市場：依給藥途徑、應用、最終用戶、生產地、濃度、病患年齡層、通路和地區分類

氫可酮藥物市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、地區和競爭對手分類，2021-2031年

氫可酮市場規模、佔有率和成長分析（按劑型、分銷通路、應用、最終用戶和地區分類）－2026-2033年產業預測

FAQ

氫可酮、Buprenornhine及其他藥物市場：按藥物、應用、給藥途徑、分銷管道和地區分類